ENDO: Liraglutide May Prevent Lipolysis, Ketogenesis in T1D (CME/CE)

(MedPage Today) -- Favorable results from placebo-controlled trial
via ENDO: Liraglutide May Prevent Lipolysis, Ketogenesis in T1D (CME/CE)
by